We tested an experimental weight loss drug. The results were "terrifying."

Read the original at CBS News ↗
Cite

Geller, L., & Yamaguchi, A. (2026, October 21). We tested an experimental weight loss drug. The results were "terrifying.". CBS News. https://www.cbsnews.com/news/tested-experimental-weight-loss-drug-results/

Dated from the outlet's own feed. Check the original for its byline.

CBS News · collected 2026-10-21 · by Laura Geller, Adam Yamaguchi

Quick Summary

CBS News national correspondent Adam Yamaguchi ordered an experimental weight-loss drug called Reta online and found it alarmingly easy to obtain without a medical consultation or prescription. When purchased from different sources, the product failed quality checks; one sample did not contain the active ingredient retatrutide but instead had phenylacetic acid, commonly used in fragrances, and was contaminated with bacteria. Doctors warn that using such unverified products poses significant health risks.
Written locally by qwen2.5:14b on 2026-10-21, using this article's own text rather than the other coverage of the same event (that is the story summary below).

AI analysis runs on qwen2.5:14b, locally

Story summary

CBS News national correspondent Adam Yamaguchi was able to purchase an experimental weight loss drug called Reta, which is still in clinical trials by Eli Lilly, from multiple online sources and even at a corner store in Brooklyn without any medical consultation. The drug arrived easily despite claims of needing health evaluations or doctor reviews before sale. This unregulated availability raises serious concerns about the safety and oversight of experimental drugs sold to the public. Dr. Reshma Ramachandran, a Yale physician who specializes in obesity treatment, expressed alarm over how readily available these drugs have become online and in retail settings, highlighting potential risks to consumers' health.

Written for “Experimental Weight Loss Drug Tested” on 2026-10-21, grounded in this article and the 0 other(s) covering the same event.
Why this leaning score
This article does not take a side on a contested political question, so it has no leaning score. That is an answer rather than a gap: a match report or a rescue can be warmly or critically written without being left or right, and scoring it anyway is how approval of a subject gets recorded as a political position.
No political leaning scored for article 96248 · logged 2026-10-21

Story

📰 Experimental Weight Loss Drug Tested
Health · 1 article(s) covering the same event.

Compared with similar articles

This article reads unscored and hedges 11% of its claims. Each row says how that neighbour differs.
The Sydney Morning Herald
⚖️ leaning not scored 🔴 11% hedged 3 of 27 📰 publisher trust 61
“Article A discusses a surge in emergency room visits due to unapproved peptide use, while Article B describes a specific test of an experimental weight loss drug by CBS News.”
New York Post
⚖️ leaning not scored 🔴 31% hedged 5 of 16 📰 publisher trust 66
“Article A reports on deaths caused by bootleg versions of an unapproved weight loss drug, while Article B discusses a test and ease of purchase for an experimental drug in clinical trials.”
ABC News (AU)
⚖️ leaning not scored 🔴 15% hedged 2 of 13 📰 publisher trust 68
“Article A discusses a general surge in hospitalizations related to unapproved peptides across NSW hospitals, while Article B focuses on a specific test of an experimental weight loss drug by CBS News.”
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
37
sentences that state something as happening or true
Uncertain
11%
4 of 37 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
66/100
CBS News's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-10-21 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

CBS News · 3439 article(s) · 6 correction(s) detected
Running correction rate · 6 correction(s)

Who wrote this

Laura Geller
2 article(s) here · 1 carrying a prediction
🔮 The site said a doctor would review his intake form.
🔮 The guidelines are being updated, and the final clinical guidance will be issued shortly, the Pentagon said.
Also by Laura Geller
Nothing else under this byline is closely related to this article, so these are simply their most recent.
Adam Yamaguchi
3 article(s) here · 1 carrying a prediction
🔮 The site said a doctor would review his intake form.
🔮 The FBI fears the arrested at LAX on Sunday may try to flee the country if released after her court hearing on Wednesday, law enforcement sources told CBS News.
🔮 "If the PRC [People's Republic of China] wish to obtain leverage over the President of Taiwan during any potential conflict, the location and pictures of the close relatives of a high-ranking Taiwanese government official, including pictures of their homes and cars, could be useful to the PRC," wrote FBI Special Agent Kevin Holt in the Oct. 3, 2026, criminal complaint.
Also by Adam Yamaguchi
Nothing else under this byline is closely related to this article, so these are simply their most recent.

Topics

Brooklyn CBS News FDA Reset Wellness Reta

Subjects

CBS News ORG · 4× Galpin PERSON · 3× Yamaguchi PERSON · 3× Brooklyn GPE · 2× Eli Lilly ORG · 2× FDA ORG · 2× Ramachandran PERSON · 2× Adam Yamaguchi PERSON · 1× Bodystreet Jupiter ORG · 1× Reset Wellness ORG · 1×

Narrative

First, CBS News national correspondent Adam Yamaguchi placed an online order through the website for Reset Wellness, a clinic started by a nurse practitioner, for 20 milligrams of experimental peptide drug that Eli Lilly is studying as a next-generation obesity treatment.
framing: assertive · carried by 1 article(s) · first seen 2026-10-21
🔮 The site said a doctor would review his intake form.

Claims (37 extracted, 4 hedged)

A drug that's not FDA approved and still in clinical trials is being advertised all over the internet. asserted
that → approve → internet
Buying it turned out to be alarmingly easy. asserted
Buying → buy → it
First, CBS News national correspondent Adam Yamaguchi placed an online order through the website for Reset Wellness, a clinic started by a nurse practitioner, for 20 milligrams of experimental peptide drug that Eli Lilly is studying as a next-generation obesity treatment. asserted
Lilly → place → treatment
At checkout, he was promised a health evaluation, but the product arrived a week later without ever having to speak to a health professional. . asserted
product → promise → professional
The weight-loss medication, known as Reta, is anNext, he purchased Reta from the website for Bodystreet Jupiter, a gym in Florida, after confirming he met its Body Mass Index, or BMI, requirement. asserted
he → know → requirement
The site said a doctor would review his intake form. asserted
doctor → say → form
The product arrived two days later without a consultation. asserted
product → arrive → consultation
He even found a poster advertising the product for sale over the counter, at a bodega in Brooklyn. asserted
He → find → Brooklyn
Yamaguchi was able to buy a vial labeled "Retatrutide" at the corner store for $90. asserted
Yamaguchi → buy → 90
It came with a warning on the label that read "Research use only, not for human consumption." asserted
that → come → consumption
Dr. Reshma Ramachandran, a Yale physician who has studied the growing use of peptides and weight loss medications, said it's "astounding" how easily accessible these drugs are. asserted
drugs → study → peptides
She said people who try products labeled as retatrutide are essentially acting as guinea pigs, because the drug is still in clinical trials and has not been certified as safe and effective. asserted
drug → say → trials
She said prescribing a drug should involve a conversation about a patient's medical history, the risks and whether the treatment is appropriate. asserted
treatment → say → history
University of Iowa research scientist Jason Galpin analyzed the samples for CBS News. asserted
Galpin → analyze → News
Both samples Yamaguchi bought online were consistent with a basic standard Galpin created for retatrutide, which isn't the same as the drug being studied in Eli Lilly's clinical trials. asserted
which → buy → trials
"It does not look anything like a peptide," Galpin said of the sample Yamaguchi bought at a Brooklyn corner store, which was labeled as Reta. asserted
which → look → Reta
Instead, Galpin found a compound called phenylacetic acid, which he described as a filler. asserted
he → find → filler
It's commonly found in fragrances and lip balms. asserted
It → find → fragrances
Further testing by Carl Ross, director of development at the University of Iowa's Center for Biocatalysis and Bioprocessing, found 13 colonies of bacteria in the sample. asserted
testing → find → sample
He warned that injecting material contaminated with bacteria could cause an infection. " uncertain
injecting → warn → infection
As kids, we're all taught to wash out cuts if we get cut, but in this case … we're injecting bacteria under the skin where it could multiply," Ross said. uncertain
Ross → teach → skin
Ramachandran shared the concern. asserted
Ramachandran → share → concern
"What's frightening to hear is that someone who's buying this, who's spending money on this, is going to potentially get themselves very sick," she said. asserted
she → hear → this
Ramachandran said she hopes regulators can find ways to oversee these platforms as access to unapproved drugs continues to grow. asserted
access → say → drugs
"I am trying to be hopeful that there might be ways to regulate these platforms… like the horse is out of the barn and so we're going to be trying to catch up to what's our current reality of really easy access" uncertain
what → try → access
CBS News has reached out to INDR Labs, Reset, Bodystreet for comment. asserted
News → reach → comment
They have not yet responded. asserted
They → respond → ?
A spokesperson for Eli Lilly sent CBS News the following statement: "Regulated manufacturers must demonstrate quality and consistency, dose after dose. asserted
manufacturers → send → dose
Black-market sellers do not. asserted
sellers → do → ?
A single test is a snapshot, not a guarantee that the dose will be sterile or stable in two weeks, let alone that the next vial will be safe. asserted
vial → let → weeks
Giving consumers false confidence in unregulated products based on limited testing risks putting more people in harm's way. asserted
Giving → give → way
Every day FDA, DOJ and other authorities fail to act against the growing black market is another day unsuspecting consumers are put at risk. asserted
consumers → fail → risk
Third-party testing of a single sample with unknown ingredients and origin does not make an illegal product safe. asserted
product → make → ingredients
Neither does taking a previous dose without apparent harm. asserted
taking → do → harm
Consumers are gambling with their health, with no way of knowing when a dangerous vial may arrive at their door. uncertain
vial → gamble → door
CBS itself recently reported on two deaths associated with black-market retatrutide, while media outlets in the UK, Ireland, an Australia have reported serious injuries and at least one death associated with similar illicit products. asserted
outlets → report → products
Just this week, Bloomberg reported that two manufacturers formerly on FDA's Green List had been laundering product from other sources, had been contaminated with black mold and bugs, and had been destroying records." asserted
manufacturers → report → records
💬Give feedback
🕘History 🎫Support